Solid H1 performance helps Inion to narrow its loss
This article was originally published in Clinica
Anglo-Finnish orthopaedic specialist Inion has seen positive revenue growth narrow its net loss during the first half of 2008. For the six months ended June 30, the company reported sales of €2.6m ($3.8m), an increase of 12% compared to the €2.3m recorded in the first half of 2007.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals